Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 1 – 4 September 2025

View source ↗

Summary

PRAC has begun a safety review of levamisole, used to treat parasitic worm infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helminthiasis

Drugs mentioned

• Levamisole (levamisole)

Snippet

PRAC starts safety review of levamisole, a medicine used to treat parasitic worm infections